⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5907450 | 1.00 | — | — | |
| SCHEMBL384345 | 1.00 | — | — | |
| SCHEMBL5097896 | 0.69 | — | — | |
| SCHEMBL189909 | 0.69 | — | — | |
| SCHEMBL12857346 | 0.65 | — | — | |
| SCHEMBL265947 | 0.65 | — | — | |
| SCHEMBL8522934 | 0.63 | — | — | |
| SCHEMBL511477 | 0.63 | — | — | |
| SCHEMBL22242554 | 0.62 | — | — | |
| SCHEMBL3791441 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12104106-B2 | Compositions of chiral molecules and perovskite nanocrystals and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2024-10-01 | — | — | US | claimed |
| CN-117660389-A | Transaminase mutant and application thereof in preparation of chiral amine compounds | 浙江容锐科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-20220326082-A1 | CHIRAL HETEROSTRUCTURES | Alliance for Energy Innovation, LLC | 2022-10-13 | — | — | US | claimed |
| CN-114134126-A | Application of transaminase and mutant thereof in preparation of (S) -1-methoxy-2-propylamine | 浙江大学杭州国际科创中心 | 2022-03-04 | — | — | CN | claimed |
| EP-2234962-B1 | METHOD FOR PRODUCING (S)-2-AMINO-1-PROPANOL (L-ALANINOL) FROM (S)-1-METHOXY-2-PROPYLAMINE | BASF SE (DE) | 2013-10-16 | — | — | EP | claimed |
| US-8344182-B2 | Process for the preparation of (S)-2-amino-1-propanol (L-alaninol) from (S)-1-methoxy-2-propylamine | BASF SE (DE) | 2013-01-01 | — | — | US | claimed |
| US-20100240928-A1 | PROCESS FOR THE PREPARATION OF (S)-2-AMINO-1-PROPANOL (L-ALANINOL) FROM (S)-1-METHOXY-2-PROPYLAMINE | BASF SE (DE) | 2010-09-23 | — | — | US | claimed |
| US-20260042774-A1 | CAMPTOTHECIN-7-ETHYLAMINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | HANGZHOU ADCORIS BIOPHARMA CO LTD (CN) | 2026-02-12 | — | — | US | disclosed |
| US-20250223306-A1 | TEAD INHIBITORS AND METHODS OF USE | SPOROS BIOVENTURES, INC., | 2025-07-10 | — | — | US | disclosed |
| US-12289941-B2 | Chiral heterostructures | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2025-04-29 | — | — | US | disclosed |
| WO-2024220641-A1 | 1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 USEFUL FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | VANDERBILT UNIVERSITY (US) | 2024-10-24 | — | — | WO | disclosed |
| US-20240327332-A1 | Process for Producing NAA and (S)-NAA | SYNGENTA CROP PROTECTION AG (CH) | 2024-10-03 | — | — | US | disclosed |
| US-12104106-B2 | Compositions of chiral molecules and perovskite nanocrystals and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2024-10-01 | — | — | US | disclosed |
| US-20040106559-A1 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-06-03 | — | — | US | disclosed |
| US-20040029859-A1 | Compounds useful in therapy | PFIZER INC. | 2004-02-12 | — | — | US | disclosed |
| US-20030236304-A1 | Fluorobenzamides and uses thereof | F. HOFFMANN-LA ROCHE AG (CH) | 2003-12-25 | — | — | US | disclosed |
| US-6660736-B2 | MAO-B inhibitors | HOFFMANN-LA ROCHE INC. | 2003-12-09 | — | — | US | disclosed |
| US-20030225053-A1 | Compounds useful in treating cytokine mediated diseases | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2003-12-04 | — | — | US | disclosed |
| US-20030195208-A1 | PHTHALIMIDO DERIVATIVES AND A PROCESS FOR THEIR PREPARATION | HOFFMANN-LA ROCHE INC. | 2003-10-16 | — | — | US | disclosed |
| WO-2003076427-A1 | QUINAZOLINE COMPOUNDS USEFUL IN THERAPY | PFIZER LIMITED (GB) | 2003-09-18 | — | — | WO | disclosed |